We are live on ! Find out more
DRIO icon

DarioHealth

60 hedge funds and large institutions have $101M invested in DarioHealth in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more capital inflows, than outflows

Capital inflows: $15.3M | Capital outflows: $6.49M

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

5% more funds holding

Funds holding: 57 → 60 (+3)

3.21% more ownership

Funds ownership: 43.55% → 46.75% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 18

40% less call options, than puts

Call options by funds: $970K | Put options by funds: $1.62M

Holders
60
Holders Change
+3
Holders Change %
+5.26%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
18
Reduced
18
Closed
6
Calls
$970K
Puts
$1.62M
Net Calls
-$646K
Net Calls Change
+$775K

DRIO Hedge Fund Activity: Q4 2021 in Review

60 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q4 2021, worth a combined $101M — up 2.4% from $98.2M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new DRIO positions and 6 closed out — a net gain of 3 holders — while 18 added to existing stakes and 18 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $5.29M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $911K sold.

  • 60 institutional investors held DarioHealth (DRIO) as of Q4 2021, up from 57 in Q3 2021.
  • Funds reported $101M of DarioHealth stock for Q4 2021, up 2.4% quarter-over-quarter.
  • 9 funds opened new DarioHealth positions in Q4 2021 and 6 closed out, a net change of +3 holders.
  • The largest DarioHealth buyer in Q4 2021 was Nantahala Capital Management, an estimated $5.29M added.
  • The largest DarioHealth seller in Q4 2021 was GSA Capital Partners, an estimated $911K sold.

Based on aggregated 13F filings for Q4 2021.